期刊文献+

颅内透明细胞型脑膜瘤(附21例报告) 被引量:5

Intracranial clear cell meningioma(repot of 21 cases and literature review)
原文传递
导出
摘要 目的 探讨颅内透明细胞型脑膜瘤(CCM)的临床特征和外科治疗.方法 回顾性分析首都医科大学附属北京天坛医院神经外科2003年1月至2013年8月收治并经组织病理学证实的21例颅内CCM患者的临床资料,包括影像学、手术情况、组织病理学和随访结果.结果 21例CCM占同期颅内脑膜瘤的0.23% (21/9 167),其中男7例,女14例,平均年龄27.5岁.肿瘤位于幕上10例,颅底11例,幕上CCM瘤周水肿发生率为80% (8/10),水肿明显且范围较大;颅底CCM对周围硬膜及骨质破坏发生率达73% (7/11).首次手术按照脑膜瘤切除程度Simpson分级:Ⅰ级7例,Ⅱ级和Ⅲ级各3例,Ⅳ级8例.8例行Ki-67增值指数检测,平均值为11.25% (5% ~30%).20例获得随访,平均随访时间为41个月(11 ~ 137个月),肿瘤复发率为60% (12/20),死亡3例(15%).首次术后行伽玛刀治疗5例,射波刀治疗1例.结论 颅内CCM是中枢神经系统较少见的脑膜瘤亚型,影像学及组织病理学特点不同于良性脑膜瘤.手术切除虽是治疗CCM的主要手段,但全切率低,易复发.残余肿瘤行伽玛刀治疗可降低复发率和延长复发时间. Objective To investigate the clinical features and treatment of intracranial clear cell meningioma.Methods We retrospectively reviewed 21 cases of intracranial clear cell meningioma hospitalized in our institute between 2003 and 2013.The clinical data included the images,surgical treatment,immunohistochemistry and the results of follow-up.Results The 21 patients who constituted 0.23% of the total 9 167 intracranial meningiomas included 7 males and 14 females.The average age was 27 years old.The edema rate of the 10 cases in the superior tentorium region was 80%,and the damage rate of the 11 skull base tumors to the surrounding bone and periosteom was 73%.Resection of Simpson Ⅰ grade was achieved in 7 patients,Simpson Ⅱ in 3,Simpson Ⅲ in 3 cases and Simpson Ⅳ in 8.The average Ki-67 index was 11.25%.The mean follow-up period was 41 months,and 20 cases were followed-up.3cases died.5 cases were treated with gamma knife after the first operation,and 1 case accepted Cyberknife.Conclusions Intracranial CCM was a rare subtype of the intracranial meningiomas.Its imaging and histopathologic characteristics were different from those of benign meningiomas.Surgical resection was the main treatment,but it is difficult to reach entirely total resection.A high recurrence rate was found in intracranial CCM.Gamma knife surgery for the residual tumor could prolong the recurrence time and reduce the recurrence rate.
出处 《中华神经外科杂志》 CSCD 北大核心 2014年第12期1197-1200,共4页 Chinese Journal of Neurosurgery
关键词 中枢神经系统肿瘤 透明细胞型脑膜瘤 显微外科手术 Central nervous system neoplasms Clear cell meningioma Microsurgery
  • 相关文献

参考文献19

  • 1Claus EB, Bondy ML, Schildkraut JM, et al. Epidemiology of intr- acranial meningioma [ J ]. Neurosurgery, 2005,57 : 1088-1095 ; discussion 1088-1095.
  • 2Kleihues P, Sobin LH. World Health Organization classification of tumors[ J]. Cancer,2000,88:2887.
  • 3Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO cla- ssification of tumours of the central nervous system [ J ]. Aeta Neuropatho1,2007 ,114 :97-109.
  • 4Harkin JC, Leonard GL. Abnormal amianthoid collagen fibers in meningioma[ J]. Acta Neuropathol, 1988,76:638-639.
  • 5Seheithauer BW. Tumors of the meninges: proposed modifications of the World Health Organization classification [ J ]. Acta Neuropathol, 1990,80 : 343 -354.
  • 6Kleihues P, Burger PC, Scheithauer BW. The new WHO clas- sification of brain tumours[ J]. Brain Pathol, 1993,3:255-268.
  • 7Dubois A, Sevely A, Boetto S, et al. Clear-cell meningioma of the cauda equina[ J]. Neuroradiolagy, 1998,40:743-747.
  • 8Imlay SP, Snider TE, Raab SS. Clear-cell meningioma: diagnosis by fine-needle aspiration biopsy [ J ]. Diagn Cytopathol, 1998,18 : 131-136.
  • 9Matsui H, Kanamori M, Abe Y, et al. Muhifocal clear cell me- ningioma in the spine : a case report [ J ]. Neurosurg Rev, 1998, 21:171-173.
  • 10Zorludemir S, Scheithauer BW, Hirose T, et al. Clear cell meni- ngioma. A clinicopathologic study of a potentially aggressive variant of meningioma[ J ]. &In J Surg Pathol, 1995,19:493-505.

二级参考文献43

  • 1张健,朱树干,孟斌,迟令懿,宫杰,李峰.非典型性脑膜瘤26例[J].中华外科杂志,2006,44(22):1569-1570. 被引量:8
  • 2陈柄桓.立体定向放射神经外科学[M].,1994,12..
  • 3Borovish B, Doron Y. Recurrence of intracranial meningiomas: the role played by regional multicentricity. J Neurosurg, 1986, 64: 58-63.
  • 4Mahmood A, Qureshi NH, Malik GM. Intracranial meningiomas:analysis of recurrence after surgical treatment. Acta Neurochir,1994,126:53-58.
  • 5Mathiesen T, Lindquist C, Kihlstrom L, et al. Recurrence of cranial base meningiomas. Neurosurgery, 1996, 39:2-9.
  • 6Abdel Aziz KM, Sanan A, van Loveren HR, et al. Petroclival meningiomas: predictive parameters for transpetrosal approaches.Neurosurgery, 2000,47:139-150.
  • 7Neil-Dwyer G, Lang DA, Davis A. Outcome from complex neurosurgery: an evidence based approach. Acta Neurochir, 2000,142:367-371.
  • 8Roberti F, Sekhar LN, Kalavakonda C, et al. Posterior fossa meningiomas: surgical experience in 161 cases. Surg Neurol, 2001,56:8-20.
  • 9Iwai Y, Yamanaka K, Nakajima H. The treatment of skull base meningiomas-combining surgery and radiosurgery. J Clin Neurosci,2001, 8:528-533.
  • 10Ove R, Kelman S, Amin PP, et al. Preservation of visual fields after peri - sellar gamma-knife radiosurgery. Int J Cancer, 2000, 20, 90:343-350.

共引文献33

同被引文献39

  • 1江波,孟悛非,陈应明.颅底胆脂瘤的MRI特征[J].中华放射学杂志,2004,38(12):1294-1297. 被引量:19
  • 2刘玉光,吴承远,朱树干.恶性脑膜瘤22例临床分析[J].中华神经外科杂志,2006,22(10):617-619. 被引量:18
  • 3Casey A,Maguire M Sarah?Bovenberg Matheus Hw,et al.Triple bioluminescence imaging for in vivo monitoring of cellular processes[J].Molecular therapy.Nucleic acids,2013,2(1):99-100.
  • 4Xiang-Jun,Ji Sui-Hua,Chen Lint,et al.Knockdown of NF-E2-re-lated factor 2 inhibits the proliferation and growth of U251MG human glioma cells in a mouse xenograft model[J].Oncology reports,2013,30(1):157-164.
  • 5Benatar-Haserfaty J,Ly-Liu D,Gonzalez-Moreno V,et al,A-nalysis of the stay and morbidity and mortality rates in a unit for neurocritical patients following surgery for a brain tumour[J].Rev Neurol,2015,60(7):296-302.
  • 6Milburn-McNulty P,Larner AJ.Transient global amnesia and brain tumour:chance concurrence or aetiological association? Case report and systematic literature review[J].Case Rep Neu-rol,2015,7(1):18-25.
  • 7Goldwirt L,Beccaria K,Carpentier A,et al.Preclinical impact of bevacizumab on brain and tumor distribution of irinotecan and temozolomide[J].J Neurooncol,2015,122(2):273-281.
  • 8He XZ,Wang QF,Han S, et al.Cryo-ablation improves anti-tumor immunity through recovering tumor educated dendritic cells in tumor-draining lymph nodes[J],Drug Des Devel Ther,2015,10(9):1449-1458.
  • 9Riemenschneider MJ,Perry A,lReifenberger G. Histological classi- fication and molecular genetics of meningiomas[ J]. Lancet Neurol, 2006, 5 ( 12 ) : 1045-1054. DOI: 10. 1016/S1474-4422 ( 06 ) 70625-1.
  • 10Claus EB, Bondy ML, Schildkraut JM, et al. Epidemiology of intracranial meningioma [ J ]. Neurosurgery, 2005,57 ( 6 ) : 1088- 1095 ;discussion 1088-1095.

引证文献5

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部